北上腺素和多布他胺诱导的动态左心室外流通道阻塞是由缩前部运动引起的
Tran Duc Hung1, Pham Vu Thu Ha1, Do Van Chien2
1Cardiovascular Center, Military Hospital 103, Vietnam Military Medical University, Hanoi, Vietnam.
Journal of medical cases
|May 8, 2024
概括
本案例研究突出表明,在急性心肌梗塞 (MI) 患者中,因缩前部运动 (SAM) 而导致的左心室外流通道动态阻塞 (LVOTO) 如何导致诺拉基尼和多布他胺. 通过心声回声扫描及时诊断和治疗对于血液动力学稳定至关重要.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
- 临床心声扫描 临床心声扫描 临床心声扫描
背景情况:
- 急性心肌梗塞 (MI) 可能会带来复杂的血液动力学挑战.
- 在治疗心脏病性休克时,使用像诺阿基因和多布胺这样的内类药物是很常见的.
- 动态左心室外流管阻塞 (LVOTO) 是一种罕见但严重的并发症.
研究的目的:
- 描述一种药物诱导的LVOTO和缩前部运动 (SAM) 在急性前部MI的背景下.
- 强调心声回声学在识别SAM和相关并发症方面的诊断作用.
- 为了说明这种特定的血液动力学并发症的管理策略.
主要方法:
- 一个76岁的急性前部心脏病发作患者的病例报告.
- 利用心声回声学来评估左心室外流通道 (LVOT) 的动态.
- 在无otropic疗法和随后的管理期间监测血液动力学参数.
主要成果:
- 上腺素和多布他胺的使用导致了动态的LVOTO和SAM.
- 低血压和新的心脏是关键的临床指标.
- 心声扫描证实了SAM和相关的额头肌吐.
- 停止内和液体复苏使患者的血液动力学稳定.
结论:
- 上腺素和多布胺的密集使用可以在急性心脏病中导致动态LVOTO和SAM的沉.
- 声心图对于诊断SAM和区分其与其他机械并发症至关重要.
- 及时识别和管理潜在的病理生理学对于防止血液动力学妥协至关重要.
更多相关视频
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
3.0K
03:40Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
285
相关概念视频
01:22Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422